Steinman Lawrence

Steinman Lawrence is listed in filings as Director at Pasithea Therapeutics Corp.. This profile follows SEC Form 4 activity through May 5, 2026, including purchase activity. Recent filings connect the profile to Pasithea Therapeutics Corp. (KTTAW), Pasithea Therapeutics Corp. (KTTA), BioAtla, Inc. (BCAB), and Ethzilla Corp. (ETHZ). The current snapshot covers public activity from Jun 14, 2024 to May 5, 2026. Reported amounts are shown as $128.5K to $173.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.